Australia Bayer Australia Ltd / Deloitte Touche Tohmatsu Limited. / Deloitte Access Economics Pty Ltd. / Bayer Australia Ltd. / /
Continent
Asia / Europe / /
Country
Australia / New Zealand / /
Facility
Statistics AIHW Australian Institute of Health / /
IndustryTerm
economics / gross domestic product / specialist health economic services / specialist services / regulatory and strategic advisory services / energy / pharmaceutical and medical devices / /
MarketIndex
BTOS / /
MedicalCondition
diabetic retinopathy / AUSDIAB Australian Diabetes / careful diabetes / hypertension / Diabetic Retinopathy A / cancer / diabetes blindness / disease / DALYs measure disease / CVD cardiovascular disease CWS / diabetic eye disease / diabetes / DR diabetic retinopathy DSP Disability Support Pension DWL deadweight loss ETDRS Early Treatment Diabetic Retinopathy Study FA / epidemic proportions / diabetes mellitus / Obesity / people developing diabetes / complex / chronic condition / high blood pressure / eye disease / Definitions Definitions Diabetes A / blindness / /
MedicalTreatment
laser treatment / /
Organization
Statistics AIHW Australian Institute of Health / World Health Organization / Glossary Glossary ABS Australian Bureau / World Health Organization WTP / Macular Disease Foundation Australia / Therapeutic Goods Administration / Australia OBPR office of Best Practice Regulation / OAA Optometrists Association / NHS / Medicare / /
Person
Jim Runciman / Rob Cummins / Greg Johnson / Craig Bennett / Diabetic Retinopathy / Julie Heraghty / /
The economic impact of diabetic macular oedema in Australia Bayer Australia Ltd APRIL 2015